1. 1. Ferlay, J., Soerjomataram, I., Ervik, M., et al. (2013) GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11. Lyon, France: International Agency for Research on Cancer. Retrieved March 3, 2016 from: http://globocan.iarc.fr
2. 2. Global Cancer Facts & Figures 3rd Edition. Retrieved March 5, 2016 from http://www.cancer.org/acs/groups/content/@research/
3. 3. Bussolati, G. & Sapino, A. (2012). Mucinous carcinoma and carcinoma with signet-ring-cell differentiation. In Lakhani S., Ellis I., Schnitt S., et al. (Eds.) WHO Classification of Tumours of the Breast 4th ed. (pp 60-61). Lyon: IARC Press.
4. 4. Cao, A.Y., He, M., Liu, Z.B., Di, G.H., Wu, J., Lu, J.S., Liu, G.Y., Shen, Z.Z. & Shao, Z.M. (2012). Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China. Ann Surg Oncol. Sep 19(9):3019-27. doi: 10.1245/s10434-012-2322-6. 19:3019–3027.
5. 5. Bae, S.Y., Choi, M.Y., Cho, D.H., et al. (2011). Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis. J Breast Cancer. 14:308–13. doi: 10.4048/jbc.2011.14.4.308.